Holdings
Global X Genomics & Biotechnology ETF
As of May 31, 2026, Global X Genomics & Biotechnology ETF reported 48 positions worth US$51.6M. Largest: Guardant Health, Inc., Illumina, Inc. and Natera, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Guardant Health, Inc. | 24,059 | US$3.12M | −2,202 | May 31, 2026 |
| Illumina, Inc. | 16,512 | US$2.69M | −3,461 | May 31, 2026 |
| Natera, Inc. | 10,370 | US$2.32M | +527 | May 31, 2026 |
| Biomarin Pharmaceutical Inc. | 39,792 | US$2.28M | +3,194 | May 31, 2026 |
| Arrowhead Pharmaceuticals, Inc. | 29,150 | US$2.27M | −17,957 | May 31, 2026 |
| Praxis Precision Medicines, Inc. | 6,388 | US$2.24M | −3,309 | May 31, 2026 |
| Twist Bioscience Corporation | 33,087 | US$2.21M | +7,450 | May 31, 2026 |
| Vertex Pharmaceuticals Incorporated | 4,923 | US$2.2M | +372 | May 31, 2026 |
| Crispr Therapeutics Ag | 38,191 | US$2.15M | +7,853 | May 31, 2026 |
| Veracyte, Inc. | 43,807 | US$2.03M | +9,595 | May 31, 2026 |